P V Wagh1, J Lippes. 1. Department of Biochemical Pharmacology, School of Pharmacy, State University of New York, Buffalo.
Abstract
OBJECTIVE: To investigate whether human oviductin-I (hOV-I) from human oviductal fluid (hOF) and human alpha-fetoprotein (hAFP) are identical molecules. DESIGN: Comparison of amino acid and carbohydrate composition of hOV-I with that of hAFP. Isolation of hAFP from oviductal fluid of a patient and evaluation of its immunochemical properties in relation to hOV-I and authentic hAFP standard. SETTING: Procedures were performed in an academic research environment. PATIENTS: Human oviductin-I was isolated from a pooled sample of hOF obtained from four patients in a third world country. AFP was purified from a sample of oviductal fluid obtained from a single patient during her periovulatory period. INTERVENTIONS: Human oviductal fluid was collected coincident to elective tubal ligations. MAIN OUTCOME MEASURES: The amino acid and carbohydrate composition of hOV-I was determined. AFP was purified from hOF using ion-exchange chromatography and gel filtration. The identity between hOV-I and hAFP from hOF was assessed using enzyme-linked immunosorbent assay (ELISA) and Western immunoblot analysis. RESULTS: The amino acid and carbohydrate composition of hOV-I indicated similarities between hOV-I and hAFP. Both hOV-I and hAFP reacted with mouse anti-hAFP monoclonal antibody and purified polyclonal rabbit anti-hOV-I immunoglobulin G in an identical manner as observed by noncompetitive ELISA. Purified AFP from hOF of a single patient had a molecular mass of 66 kd and was found to be identical with hOV-I by Western immunoblot analysis. CONCLUSIONS: Human oviductin-I and hAFP are chemically similar and immunologically identical molecules. We believe that this finding is the first documentation for the existence of AFP in hOF.
OBJECTIVE: To investigate whether human oviductin-I (hOV-I) from human oviductal fluid (hOF) and humanalpha-fetoprotein (hAFP) are identical molecules. DESIGN: Comparison of amino acid and carbohydrate composition of hOV-I with that ofhAFP. Isolation ofhAFP from oviductal fluid of a patient and evaluation of its immunochemical properties in relation to hOV-I and authentic hAFP standard. SETTING: Procedures were performed in an academic research environment. PATIENTS: Human oviductin-I was isolated from a pooled sample ofhOF obtained from four patients in a third world country. AFP was purified from a sample of oviductal fluid obtained from a single patient during her periovulatory period. INTERVENTIONS:Human oviductal fluid was collected coincident to elective tubal ligations. MAIN OUTCOME MEASURES: The amino acid and carbohydrate composition of hOV-I was determined. AFP was purified from hOF using ion-exchange chromatography and gel filtration. The identity between hOV-I and hAFP from hOF was assessed using enzyme-linked immunosorbent assay (ELISA) and Western immunoblot analysis. RESULTS: The amino acid and carbohydrate composition of hOV-I indicated similarities between hOV-I and hAFP. Both hOV-I and hAFP reacted with mouse anti-hAFP monoclonal antibody and purified polyclonal rabbit anti-hOV-I immunoglobulin G in an identical manner as observed by noncompetitive ELISA. Purified AFP from hOFof a single patient had a molecular mass of 66 kd and was found to be identical with hOV-I by Western immunoblot analysis. CONCLUSIONS:Human oviductin-I and hAFP are chemically similar and immunologically identical molecules. We believe that this finding is the first documentation for the existence ofAFP in hOF.